LoweryRG, VogelK, TillJ. ADP detection technologies. Assay Drug Dev Technol, 201010.1089/adt.2010.0987.letlowwww.liebertonline.com/doi/pdfplus/10.1089/adt.2010.0987.letlow.
2.
ZegzoutiH, ZdanovskaiaM, HsiaoK, GoueliSA. ADP-Glo: a bioluminescent, homogeneous ADP monitoring assay for kinases. Assay Drug Dev Technol, 2009; 7:560–572. www.liebertonline.com/doi/pdfplus/10.1089/adt.2009.0222.
3.
VidugirieneJ, ZegzoutiH, GoueliSA. Evaluating the utility of a bioluminescent ADP-detecting assay for lipid kinases. Assay Drug Dev Technol, 2009; 7:585–597. www.liebertonline.com/doi/pdfplus/10.1089/adt.2009.0223.
4.
LiuY, ZalamedaL, KimKW, WangM, McCarterJD. Discovery of acetyl-coenzyme a carboxylase 2 inhibitors: comparison of a fluorescence intensity-bas phosphate assay, a fluorescence polarization-based ADP assay for high-throughput screening. Assay Drug Dev Technol, 2007; 5:225–236. www.liebertonline.com/doi/pdfplus/10.1089/adt.2006.045.
5.
HongL, QuinnCM, JiaY. Evaluating the utility of the HTRF Transcreener ADP assay technology: a comparison with the standard HTRF assay technology. Anal Biochem, 2009; 391:31–38.
6.
LiH, TotoritisRD, LorLA, SchwartzB, CaprioliP, JurewiczAJ, ZhangG. Evaluation of an antibody-free ADP detection assay: ADP-Glo. Assay Drug Dev Technol, 2009; 7:598–605. www.liebertonline.com/doi/pdfplus/10.1089/adt.2009.0221.
7.
KupchoK, StafslienDK, SinghU, EliasonHC, ReichlingL, FrazeeWJet al.The Adapta universal kinase assay: a superior alternative to luciferase-based kinase assays. tools.invitrogen.com/contents/sfs/posters/0108-Adapta-poster-comparison-to-Kinase-Glo.pdf.
8.
ZhangJH, ChungTD, OldenburgKR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen, 1999; 4:67–73.
